Apiject announced today that it signed a lease on a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North Carolina. The injection delivery system developer plans for the new facility to house two advanced blow-fill-seal (BFS) production lines and serve as an outsourcing facility focused on producing essential generic injectable medicines currently on the FDA’s drug shortage […]
Drug-Device Combinations
Abbott reportedly looks to expand CGM manufacturing plant in Ireland
Kilkenny Live reports that Abbott (NYSE:ABT) is seeking permission to expand its facility in Kilkenny, Ireland. According to the report, Abbott hopes to extend its existing industrial building and alter its vehicle entrance and parking lot at the IDA Business and Technology Park in Kilkenny. The report states that the proposed extension would result in […]
ENvue Medical launches OTC reusable syringes
ENvue Medical (Nasdaq:NAOV) announced today that it launched a line of over-the-counter (OTC) ENFit syringes. The Tyler, Texas-based company — formerly NanoVibronix — said the OTC syringes aim to meet both feeding and medication delivery needs. NanoVibronix said last year that it was shifting its focus to ENvue and its feeding tube technology after it […]
New Dexcom CEO Jake Leach talks 2026 roadmap, next-gen tech
After more than 100 days in the corner office at CGM maker Dexcom (NSDQ:DXCM), CEO Jake Leach is excited for the company’s future. In July, Leach was tapped to take the CEO role permanently at the start of 2026 as part of Dexcom’s planned succession process. He took over a few months early as outgoing […]
Sequel Med Tech, Diabeloop to integrate automated insulin delivery algorithm into twiist pump
Sequel Med Tech and Diabeloop today announced a collaboration to integrate a new algorithm into the twiist automated insulin pump. The partnership aims to bring DBLG2, Diabeloop’s newest automated insulin delivery (AID) algorithm, to twiist. DBLG2 picked up FDA clearance last month. Sequel becomes the latest pump maker to adopt the algorithm, with ViCentra planning to […]
West sells manufacturing, supply rights for on-body drug delivery system to AbbVie
West Pharmaceutical Services (NYSE:WST) announced that it reached an agreement to sell on-body drug delivery technology to AbbVie. The company agreed to sell all manufacturing and supply rights for the SmartDose 3.5mL on-body system and associated facilities. Exton, Pennsylvania-based West said the deal includes a total consideration of $112.5 million at close. It expects the […]
BD to invest $110M to support prefilled syringe production, pharma supply chain
BD (NYSE:BDX) announced today that it invested $110 million to expand its production of prefillable syringes in Columbus, Nebraska. Franklin Lakes, New Jersey-based BD aims to expand prefillable syringe production to accelerate biologic and GLP-1 drug delivery and support pharmaceutical reshoring in the U.S. The investment brings the company’s Neopak glass prefillable syringe production to […]
Dexcom stock rises on Street-beating preliminary Q4 sales
Dexcom (NSDQ:DXCM) today announced preliminary fourth-quarter results that included revenues that topped the consensus forecast. For the quarter ended Dec. 31, 2025, the company expects total revenue of $1.26 billion. That marks a 13% increase over the same period a year ago and lands just ahead of expectations on Wall Street. Dexcom expects to report […]
Medtronic wins FDA clearance for MiniMed Go app for InPen smart insulin pen
Medtronic (NYSE:MDT) announced today that the FDA granted 510(k) clearance for its MiniMed Go app for multiple daily injections (MDI). MiniMed Go, a smart MDI system, integrates the InPen smart insulin pen with the Instinct sensor made by Abbott. It all integrates within the app to deliver real-time, personalized insights and actionable guidance. Medtronic and […]
CamDiab earns CE mark for fully closed-loop insulin delivery algorithm
CamDiab announced that it received European approval for its fully closed-loop automated insulin delivery algorithm. The algorithm allows users to manage their type 1 diabetes without needing to count carbohydrates or providing pre-meal insulin. Cambridge, UK-based CamDiab said it marks the world’s first commercially available automated insulin delivery algorithm that enables people with type 1 […]










